Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast Cancer

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00538525

Enrollment

Registered

2007-10-02

Start date

2007-09-30

Completion date

2008-04-30

Last updated

2012-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

Phase II study of neoadjuvant chemotherapy with Doxorubicin followed by Docetaxel-Cisplatin in locally advanced breast cancer

Interventions

DRUGDoxorubicin, Docetaxel, Cisplatin

Doxorubicin, Docetaxel, Cisplatin

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients with locally advanced breast cancer

Exclusion criteria

* Patients with metastatic breast cancer

Design outcomes

Primary

Measure	Time frame
Effectiveness	overall

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026